Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT06772480
Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)
Thalidomide Versus Argon Plasma Coagulation in Gastric Antral Vascular Ectasia(GAVE)-Related Anaemia in Cirrhosis (TAG Trial)- A Randomised Controlled Trial
Sponsor: Institute of Liver and Biliary Sciences, India
Conditions
Gastric Antral Vascular Ectasia Liver Cirrhosis
Interventions
Argon Plasma Coagulation Thalidomide
Updated 1 time since 2025 Last updated: Jan 8, 2025 Started: Jan 5, 2025 Primary completion: Jan 31, 2026 Completion: Jan 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Gastric Antral Vascular Ectasia and Liver Cirrhosis, this trial is actively recruiting participants. The trial is conducted by Institute of Liver and Biliary Sciences, India and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Institute of Liver and Biliary Sciences, India
Data source: Institute of Liver and Biliary Sciences, India
For direct contact, visit the study record on ClinicalTrials.gov .